Acute Renal Failure (ARF) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Acute Renal Failure (ARF) Marketed and Pipeline Drugs Report Overview
Acute Renal Failure (ARF) or Acute Kidney Injury (AKI) is a sudden episode of kidney failure or kidney damage that happens within a few hours or a few days. ARF causes a buildup of waste products in the blood and makes it hard for the kidneys to keep the right balance of fluid in your body. ARF can also affect other organs, such as the brain, heart, and lungs. This is common in patients who are in the hospital, in intensive care units, and especially in older adults.
Key Mechanism of Action (Marketed) | · Transporter Inhibitor
· Receptor Agonists |
Key Routes of Administration (Marketed) | · Injection
· Oral |
Key Molecule Types (Marketed) | · Small Molecules
· Biologics |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
The Acute Renal Failure (ARF) marketed and pipeline drugs market research report includes an assessment of the disease’s epidemiology, leading marketed products with sales forecasts, pricing and reimbursement, and late-to-mid-stage pipeline products with a phase transition success rate (PTSR) and likelihood of approval (LoA) for ARF. The report also analyzes the clinical and commercial landscapes of ARF, as well as an assessment of deals, future market catalysts, key market players, and the future competitive environment.
Key Mechanisms of Action (Pipeline) | · Enzyme Inhibitors
· Receptor Agonists · Protein and Peptide Activators · Protein and Peptide Inhibitors · Ligand Scavengers · Receptor Antagonists · Enzyme Activators · Ion Channel Blockers |
Key Routes of Administration (Pipeline) | · Injection
· Oral · Topical · Inhalational |
Key Molecule Types (Pipeline) | · Small Molecules
· Biologics · Oligonucleotides · Polymers |
Top Sponsors (Marketed and Pipeline Drugs) | · Shahid Beheshti University of Medical Sciences
· Yonsei University · Arak University of Medical Sciences · Sahlgrenska University Hospital · Renibus Therapeutics Inc |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
ARF Marketed Drugs Segmentation by Mechanisms of Action
Most of the marketed drugs for ARF are transport inhibitors followed by receptor agonists.
ARF Marketed Drugs Analysis by Mechanisms of Action, 2023 (%)
Buy the Full Report to Know More about the MoA of ARF Marketed Drugs
ARF Marketed Drugs Segmentation by Routes of Administration
Most marketed therapies are administered by injectable route, followed by oral administration.
ARF Marketed Drugs Analysis by Routes of Administration, 2023 (%)
Buy the Full Report to Know More about the RoA of ARF Marketed Drugs
ARF Marketed Drugs Segmentation by Molecule Types
The majority of marketed products for ARF are small molecules, followed by biologics.
ARF Marketed Drugs Analysis by Molecule Types, 2023 (%)
Buy the Full Report to Know More about the Molecule Types of ARF Marketed Drugs
ARF Pipeline Drugs Market Segmentation by Mechanisms of Action
The ARF pipeline mainly includes enzyme inhibitors and receptor agonists, followed by protein and peptide activators, protein and peptide inhibitors, ligand scavengers, receptor antagonists, enzyme activators, and ion channel blockers, among others.
ARF Pipeline Drugs Market Analysis by Mechanisms of Action, 2023 (%)
Buy the Full Report to Know More about the MoA of ARF Pipeline Drugs
ARF Pipeline Drugs Market Segmentation by Routes of Administration
Most pipeline drugs for ARF are injection therapies, closely followed by oral drugs. Other pipeline drugs follow the topical and inhalational route.
ARF Pipeline Drugs Market Analysis by Routes of Administration, 2023 (%)
Buy Full Report to Know More about the RoA of ARF Pipeline Drugs
ARF Pipeline Drugs Market Segmentation by Molecule Types
Most pipeline drugs for ARF are small molecules, closely followed by biologic molecules. Oligonucleotide molecules and polymers in development are fewer in number than the other two.
ARF Pipeline Drugs Market Analysis by Molecule Types, 2023 (%)
Buy the Full Report to Know More about the Molecule Types of ARF Pipeline Drugs
ARF Marketed and Pipeline Drugs Market – Competitive Landscape
There are more academic sponsors and institutions than commercial sponsors among the top 20 sponsors who have backed clinical trials in the ARF space over the past 10 years. Some of the top sponsors in the ARF marketed and pipeline drugs market are Shahid Beheshti University of Medical Sciences, Yonsei University, Arak University of Medical Sciences, Sahlgrenska University Hospital, and Renibus Therapeutics Inc. In 2023, Shahid Beheshti University of Medical Sciences leads overall among the trial sponsors after adding up all the trial phases. However, among commercial sponsors, Renibus Therapeutics sponsored the highest number of trials.
ARF Marketed and Pipeline Drugs Market Analysis by Sponsors, 2023 (%)
Buy Full Report for More Sponsor Insights into the ARF Marketed and Pipeline Drugs Market Download A Free Report Sample
Segments Covered in the Report
ARF Marketed Drugs Mechanism of Action (Number of Drugs, 2023)
- Transporter Inhibitor
- Receptor Agonists
ARF Marketed Drugs Routes of Administration Outlook (Number of Drugs, 2023)
- Injection
- Oral
ARF Marketed Drugs Molecule Types Outlook (Number of Drugs, 2023)
- Small Molecules
- Biologics
ARF Pipeline Drugs Mechanisms of Action Outlook (Number of Drugs, 2023)
- Enzyme Inhibitors
- Receptor Agonists
- Protein and Peptide Activators
- Protein and Peptide Inhibitors
- Ligand Scavengers
- Receptor Antagonists
- Enzyme Activators
- Ion Channel Blockers
ARF Pipeline Drugs Routes of Administration Outlook (Number of Drugs, 2023)
- Injection
- Oral
- Topical
- Inhalational
ARF Pipeline Drugs Molecule Types Outlook (Number of Drugs, 2023)
- Small Molecules
- Biologics
- Oligonucleotides
- Polymers
Scope
Components of the report include:
- Disease Landscape
- Disease Overview
- Epidemiology Overview
- Treatment Overview
- Marketed Products Assessment
- Breakdown by Mechanism of Action, Route of Administration
- Product Profiles with Sales Forecast
- Pricing and Reimbursement Assessment
- Annual Therapy Cost
- Time to Pricing and Time to Reimbursement
- Pipeline Assessment
- Breakdown by Development Stage, Mechanism of Action, Molecule Type, Route of Administration
- Product Profiles with Sales Forecast
- Late-to-mid-stage Pipeline Drugs
- Phase Transition Success Rate and Likelihood of Approval
- Clinical Trials Assessment
- Breakdown of Trials by Phase, Status, Virtual Components, Sponsors, Geography, and Endpoint Status
- Enrolment Analytics, Site Analytics, Feasibility Analysis
- Deals Landscape
- Mergers, Acquisitions, and Strategic Alliances by Region
- Overview of Recent Deals
- Commercial Assessment
- Key Market Players
- Future Market Catalysts
Reasons to Buy
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the ARF market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global ARF market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Table of Contents
Frequently asked questions
-
Which is the leading MoA for ARF marketed drugs?
In 2023, most of the marketed drugs for ARF are transport inhibitors.
-
Which is the leading RoA for ARF marketed drugs?
In 2023, most of the marketed drugs for ARF are administered by the injectable route.
-
Which is the leading molecule type for ARF marketed drugs?
In 2023, most of the pipeline drugs for ARF are small molecules.
-
Which is the leading MoA for ARF pipeline drugs?
In 2023, most of the ARF pipeline drugs are enzyme inhibitors.
-
Which is the leading RoA for ARF pipeline drugs?
In 2023, most of the drugs in the ARF pipeline are injection therapies.
-
Which is the leading molecule type for ARF pipeline drugs?
In 2023, most of the pipeline drugs for ARF are small molecules.
-
Who are the top sponsors for ARF marketed and pipeline drugs market?
Some of the top sponsors in the ARF marketed and pipeline drugs market are Shahid Beheshti University of Medical Sciences, Yonsei University, Arak University of Medical Sciences, Sahlgrenska University Hospital, and Renibus Therapeutics Inc.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.